Navigation Links
In vitro infection and replication of hepatitis E virus in human hepatocytes
Date:4/2/2011

Groundbreaking data presented today demonstrates, for the first time, in vitro infection and replication of swine hepatitis E virus (HEV) in human hepatocytes.1

This study also verifies that HEV is a zoonosis (infectious disease that can be transmitted from animals to humans), which has been suggested for a long time.

HEV is a major cause of epidemic and acute sporadic hepatitis in many developing countries. It is also endemic in many industrialized countries, including the United States, European countries and Japan.

Four major genotypes (genotypes 1-4) of HEV have been identified in mammalian species. Genotype 3 and 4 HEVs are believed to undergo zoonotic transmission, with a reservoir in pigs and, possibly, a range of other mammals.


'/>"/>

Contact: Travis Taylor
easlpressoffice@cohnwolfe.com
44-784-306-9451
European Association for the Study of the Liver
Source:Eurekalert

Page: 1

Related biology news :

1. In vitro antibody production enables HIV infection detection in window period -- key to safer blood
2. Combined stem cell-gene therapy approach cures human genetic disease in vitro
3. Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection
4. Latest hands-free electronic water faucets found to be hindrance, not help, in infection control
5. Nanomodified surfaces seal leg implants against infection
6. BUSM faculty author commentary on the global challenges of emerging viral infections
7. Researchers step closer to treatment of virulent hospital infection
8. Toxoplasmosis: The strain explains severity of infection
9. A more definitive test for a common sexually transmitted infection
10. Chemical compounds in trees can fight deadly staph infections in humans
11. Exposure to worm infection in the womb may protect against eczema, study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2015)... GOTHENBURG, Sweden , August 11, 2015 ... sensor FPC1155. Already received as well as expected revenues in 2015 ... included in FPC,s communicated revenue guidance of approximately 2,200 MSEK for ... is a prominent smartphone manufacturer ... ZUK selected FPC1 155 ...
(Date:8/6/2015)... CITY, Calif. , Aug. 6, 2015 /PRNewswire/ ... Valley) will visit Crossmatch ™ to learn ... networks and protect data. Crossmatch is a world ... whose technologies and expertise are helping federal agencies ... efficiency and security.   "The vast ...
(Date:8/5/2015)... -- According to a new market research ... Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, Defense ... 2020", published by MarketsandMarkets, defines and segments the Physical ... The global PIAM Market is estimated to grow from ... at a CAGR of 14.9 % from 2014 to ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... Health & Science University (OHSU) and Intel Corp. ... that advance the field of personalized medicine by ... analyzing a patient,s individual genetic profile. Through a ... and scientists from the two institutions will develop ...
... developers may have a new tool to search for more ... that can model and catalogue the entire set of lightweight, ... The small-molecule universe has more than 10^60 (that,s 1 ... Beratan said that many of the world,s problems have molecular ...
... Philosophical Transactions of The Royal Society Biological Sciences ... a global population that is simultaneously growing and increasing ... and social impoverishment. According to Michael T. ... (WHRC) and one of the issue,s co-editors, "One important ...
Cached Biology News:OHSU teams with Intel to decode the root causes of cancer and other complex diseases 2OHSU teams with Intel to decode the root causes of cancer and other complex diseases 3OHSU teams with Intel to decode the root causes of cancer and other complex diseases 4OHSU teams with Intel to decode the root causes of cancer and other complex diseases 5Scientists map all possible drug-like chemical compounds 2Scientists map all possible drug-like chemical compounds 3Ecology, economy and management of an agro-industrial Amazon frontier 2Ecology, economy and management of an agro-industrial Amazon frontier 3
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic ... it has received a $1.5M Phase II SBIR ... to further develop its therapeutic agent to reduce ... need in end stage renal disease (ESRD) patients ... National Institute of Diabetes and Digestive and Kidney ...
(Date:8/26/2015)... , August 26, 2015 Israel Proves Its ... wins 1 st place  Wayerz comes in 5 ... Israel by venture capital fund JVP, with Chinese ... US, China , Israel , ... .  Impressive achievement for the Israeli representatives in the ...
(Date:8/26/2015)... -- After litigating and negotiating patent infringement claims ... United States patent RE43,651 (the ,651 ... the United States without any admission or concession ... As a result of the parties, settlement, the US District ... dismissed the case without prejudice. Under the ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, ... new business relationships with local sponsors in southern California. The Clinical Trial Management Expert ... development processes and regulatory pathways., , Stem Cell Meeting ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6P2i Settles United States Litigation 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
... Calif., Aug. 25, 2011 Emmy® and Tony® award-winning ... ) today launch Act 2 Reduce Fractures™, an educational ... for fractures. Earlier this year, Danner was diagnosed with ... to encourage women like her to educate themselves, take ...
... 25, 2011 SyntheMed, Inc. (OTC Bulletin Board: ... announced that its stockholders approved the planned merger with ... today.  In excess of 99% of the votes cast ... merger with Pathfinder was previously announced and is described ...
... Hikma Pharmaceuticals reports lower-than-expected 3.2% increase in revenues ... The international drug developer says that political ... some key countries like Egypt and Tunisia. ... Hikma CEO Said Darwazah says that production is back ...
Cached Biology Technology:Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign 2Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign 3Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign 4Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign 5Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign 6Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign 7SyntheMed, Inc. Announces Stockholder Approval of Planned Merger With Pathfinder, LLC 2SyntheMed, Inc. Announces Stockholder Approval of Planned Merger With Pathfinder, LLC 3
...
...
... The Zero Blunt TOPO PCR ... easiest method for high-efficiency (>=95%) cloning ... proofreading thermostable polymerases. The kit includes ... II-TOPO vector for 5-minute bench-top ligations ...
Carp Vitellogenin ELISA System, 96 wells. ELISARange: 5.0-225 ng/ml.Sensitivity: 5.0 ng/ml.Sample volume: 100 ul.Suitable for use with Carp plasma samples.3-h protocol.Store at 2-8 C. Category: Drug ...
Biology Products: